References

Alzheimer disease

10.1038/s41572-021-00269-y · 2021 · External reference

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

10.1186/s13024-022-00566-4 · 2022 · External reference

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

10.1016/s2468-2667(21)00249-8 · 2022 · External reference

Effect and mechanism of acupuncture on Alzheimer’s disease: A review

10.3389/fnagi.2023.1035376 · 2023 · External reference

Evidence of endothelial dysfunction in the development of Alzheimer’s disease: Is Alzheimer’s a vascular disorder?

2013 · External reference

Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

10.1016/s1474-4422(04)00683-0 · 2004 · External reference

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

10.1038/nrn3114 · 2011 · External reference

Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer’s disease

10.1111/bpa.12004 · 2013 · External reference

Olfactory deficit detected by fMRI in early Alzheimer’s disease

10.1016/j.brainres.2010.08.018 · 2010 · External reference

Brain health and shared risk factors for dementia and stroke

10.1038/nrneurol.2015.195 · 2015 · External reference

Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging

10.1016/j.neuron.2010.09.043 · 2010 · External reference

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

10.1038/nature11087 · 2012 · External reference

The role of cerebral ischemia in Alzheimer’s disease

10.1016/s0197-4580(00)00125-1 · 2000 · External reference

Alzheimer disease and cerebrovascular pathology: an update

10.1007/s007020200068 · 2002 · External reference

Incidence of cerebrovascular lesions in Alzheimer’s disease: a postmortem study

10.1007/s00401-002-0634-5 · 2003 · External reference

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

10.1038/ncomms11934 · 2016 · External reference

The role of brain vasculature in neurodegenerative disorders

10.1038/s41593-018-0234-x · 2018 · External reference

Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer’s disease

10.3233/jad-2010-091699 · 2010 · External reference

Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer’s Disease

10.3389/fnins.2016.00154 · 2016 · External reference

Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer’s disease

2004 · External reference

Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT

10.3174/ajnr.a3780 · 2014 · External reference

Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-beta-Positive Subjects in the Alzheimer’s Disease Continuum

10.1159/000439257 · 2016 · External reference

Sensitivity and specificity of diagnostic accuracy in Alzheimer’s disease: a synthesis of existing evidence

10.1177/1533317513488910 · 2013 · External reference

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

10.1016/j.neurobiolaging.2009.07.002 · 2011 · External reference

Arterial spin labeling (ASL-MRI) versus fluorodeoxyglucose-PET (FDG-PET) in diagnosing dementia: a systematic review and meta-analysis

10.1186/s12883-023-03432-y · 2023 · External reference

Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement

10.1001/jama.2017.19163 · 2018 · External reference

The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease

10.1016/j.jalz.2011.03.005 · 2011 · External reference

Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease

10.1212/wnl.34.7.939 · 1984 · External reference

Unresolved reference

1994 · External reference

10.1176/appi.books.9780890425596

10.1176/appi.books.9780890425596 · 2013 · External reference

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

10.7326/0003-4819-155-8-201110180-00009 · 2011 · External reference

The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed

10.1016/j.jclinepi.2005.01.016 · 2005 · External reference

Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease

10.3174/ajnr.a1955 · 2010 · External reference

Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease

10.1007/s00330-009-1511-6 · 2009 · External reference

Simultaneous arterial spin labeling cerebral blood flow and morphological assessments for detection of Alzheimer’s disease

10.1016/j.acra.2011.07.015 · 2011 · External reference

Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer’s disease from cognitively normal elderly adults

10.3233/jad-131868 · 2014 · External reference

Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD

10.1002/acn3.330 · 2016 · External reference

Disrupted Regional Cerebral Blood Flow, Functional Activity and Connectivity in Alzheimer’s Disease: A Combined ASL Perfusion and Resting State fMRI Study

10.3389/fnins.2019.00738 · 2019 · External reference

Quantitative analysis of cerebral blood flow in different stages of Alzheimer’s disease by arterial spin labeling

2021 · External reference

Potential Diagnostic Applications of Multi-Delay Arterial Spin Labeling in Early Alzheimer’s Disease: The Chinese Imaging, Biomarkers, and Lifestyle Study

10.3389/fnins.2022.934471 · 2022 · External reference

A diagnostic index based on pseudo-continuous arterial spin labeling and T1-mapping improves efficacy in discriminating Alzheimer’s disease from normal cognition

10.3389/fnins.2022.974651 · 2022 · External reference

Diagnosis of Alzheimer’s disease by arterial spin labeling imaging combined with cognitive scoring

2022 · External reference

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer’s disease

10.1016/j.jalz.2011.06.003 · 2012 · External reference

Clinically diagnosed Alzheimer’s disease: autopsy results in 150 cases

10.1002/ana.410240110 · 1988 · External reference

Circulating long non- coding RNAs as novel diagnostic biomarkers for Alzheimer’s disease (AD): A systematic review and meta-analysis

10.1371/journal.pone.0281784 · 2023 · External reference

Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria

10.1016/s1474-4422(07)70178-3 · 2007 · External reference

Neuroimaging through the course of Alzheimer’s disease

10.3233/jad-2010-1217 · 2010 · External reference

Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI

10.1016/j.neurobiolaging.2006.01.009 · 2007 · External reference

Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease

10.1097/wad.0b013e3182163b62 · 2012 · External reference

A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer’s disease and its prodromal stages

10.1016/j.neuroimage.2017.03.057 · 2017 · External reference

A Survey of Publicly Available MRI Datasets for Potential Use in Artificial Intelligence Research

10.1002/jmri.29101 · 2024 · External reference

The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods

10.1002/jmri.21049 · 2008 · External reference

Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults

10.1162/jocn.2009.21407 · 2010 · External reference

MIRIAD—Public release of a multiple time point Alzheimer’s MR imaging dataset

10.1016/j.neuroimage.2012.12.044 · 2013 · External reference

Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer’s disease

2014 · External reference

Systematic review and meta-analysis: multimodal functional and anatomical neural alterations in autism spectrum disorder

10.1186/s13229-024-00593-6 · 2024 · External reference

Assessment of cerebral blood flow in Alzheimer’s disease by spin-labeled magnetic resonance imaging

10.1002/1531-8249(200001)47:1<93::aid-ana15>3.0.co;2-8 · 2000 · External reference

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience

10.1148/radiol.2343040197 · 2005 · External reference

Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease

10.1212/wnl.0b013e31823a0ef7 · 2011 · External reference

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis

10.3390/cells12081184 · 2023 · External reference

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis

10.1007/s00259-015-3228-x · 2016 · External reference

Behavior, sensitivity, and power of activation likelihood estimation characterized by massive empirical simulation

10.1016/j.neuroimage.2016.04.072 · 2016 · External reference

Diagnostic Accuracy of Arterial Spin-Labeling MR Imaging in Detecting the Epileptogenic Zone: Systematic Review and Meta-analysis

10.3174/ajnr.a7061 · 2021 · External reference

Transcranial direct current stimulation (tDCS) for improving aphasia in patients with aphasia after stroke

2015 · External reference

The hippocampus and memory: insights from spatial processing

10.1038/nrn2335 · 2008 · External reference

Microvascular Alterations in Alzheimer’s Disease

10.3389/fncel.2020.618986 · 2020 · External reference

The clinical use of structural MRI in Alzheimer disease

10.1038/nrneurol.2009.215 · 2010 · External reference

A Multimodal Meta-Analytical Evidence of Functional and Structural Brain Abnormalities Across Alzheimer’s Disease Spectrum

10.1016/j.arr.2024.102240 · 2024 · External reference

Alzheimer disease: Arterial spin-labeled MRI for diagnosis and monitoring of AD

10.1038/nrneurol.2011.206 · 2011 · External reference

Arterial Spin Labeling (ASL) fMRI: advantages, theoretical constrains, and experimental challenges in neurosciences

2012 · External reference